Nasonex Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Concise Prescribing Info

Contents

Mometasone furoate monohydrate

Indications/Uses

Symptoms of seasonal or perennial rhinitis & relief of nasal congestion associated w/ seasonal allergic rhinitis. Adjunctive treatment to antibiotics for acute episodes of sinusitis. Nasal polyps & associated symptoms including congestion & loss of smell in patients ≥18 yr. Symptoms associated w/ acute rhinosinusitis w/o signs or symptoms of bacterial infection.

Click to view Nasonex detailed prescribing information

Dosage/Direction for Use

Seasonal or perennial rhinitis Adult (including geriatric patient) & adolescent 2 sprays in each nostril once daily. Maintenance: 1 spray in each nostril. Max dose: 4 sprays in each nostril once daily. Childn 2-11 yr 1 spray in each nostril once daily. Treatment of nasal congestion associated w/ seasonal allergic rhinitis Adult & adolescent ≥12 yr 2 sprays in each nostril once daily. Childn 2-11 yr 1 spray in each nostril once daily. Adjunctive treatment of acute episodes of sinusitis Adult (including geriatric patient) & adolescent ≥12 yr 2 sprays in each nostril bid. May be increased to 4 sprays in each nostril bid. Nasal polyposis Adult (including geriatric patient) & adolescent ≥18 yr 2 sprays in each nostril bid. Dose may be reduced to 2 sprays in each nostril once daily once symptoms are adequately controlled. Acute rhinosinusitis Patients ≥12 yr 2 actuations in each nostril bid.

Click to view Nasonex detailed prescribing information

Overdosage

View Nasonex overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Nasonex detailed prescribing information

Special Precautions

Should not be used in the presence of untreated localized infection involving nasal mucosa; patients who have experienced recent nasal surgery or trauma. Periodically examine for possible changes in nasal mucosa w/in long-term treatment. Discontinue treatment if localized fungal infection of the nose or pharynx develops or nasopharyngeal irritation persists. Patients w/ active or quiescent tuberculous infections of the resp tract, or untreated fungal, bacterial, systemic viral infections of ocular herpes simplex. Patients from long-term use of systemic corticosteroids; systemic corticosteroid w/drawal. Potentially immunosuppressed patients. Cases of nasal septum perforation or increased IOP. Blurred vision or other visual disturbances. Signs or symptoms of severe bacterial infection. Pregnancy & lactation. Childn & adolescents <18 yr (nasal polyposis) & <12 yr (acute rhinosinusitis).

Click to view Nasonex detailed prescribing information

Use In Pregnancy & Lactation

Click to view Nasonex detailed prescribing information

Adverse Reactions

Headache, epistaxis (ie, frank bleeding, blood-tinged mucus, & blood flecks), pharyngitis, nasal burning, irritation & ulceration. Sneezing. Sinus headache.

Click to view Nasonex detailed prescribing information

Drug Interactions

Increased plasma conc & risk of side effects w/ strong CYP3A4 inhibitors (eg, ketoconazole, itraconazole, clarithromycin, ritonavir, cobicistat-containing products).

Click to view Nasonex detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Nasonex detailed prescribing information

Storage

View Nasonex storage conditions for details to ensure optimal shelf-life.

Description

View Nasonex description for details of the chemical structure and excipients (inactive components).

Action

View Nasonex mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Nasal Decongestants & Other Nasal Preparations

ATC Classification

R01AD09 - mometasone ; Belongs to the class of topical corticosteroids used for prophylaxis and treatment of allergic rhinitis.

Thai FDA Category

Presentation/Packing

Form

Nasonex aqueous nasal spray 50 mcg/dose

Packing/Price

140 dose x 1's;60 dose x 1's

Nasonex

mometasone

Manufacturer:

Organon

Distributor:

Zuellig Pharma